Stock listing

Bioventix Plc

Selected listing: A113DD · LS · EUR · DE

Bioventix Plc (Lang & Schwarz: A113DD), Health Technology. Latest release Apr 20, 2026: Share Options Awarded.

A113DD:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A113DD
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Bioventix Plc

The company specializes in the development and commercialization of high-quality monoclonal antibodies for use in diagnostic applications. Bioventix is committed to advancing healthcare through innovative solutions in the diagnostics sector.

Latest news from Bioventix Plc

Share Options Awarded

April 20, 2026

Appointment of Non-Executive Director

February 24, 2026

Result of AGM

December 4, 2025

Director Dealing

November 26, 2025

Holding(s) in Company

November 18, 2025

All Bioventix Plc news →

Research Bioventix Plc

Bioventix Plc company profile

View the public company page for Bioventix Plc on 6ix.

Bioventix Plc news

Read company news and market updates connected to Bioventix Plc.

Bioventix Plc investor events

Find investor webinars, events, and replay context for Bioventix Plc.